CommercialAdministrativeLow impact
06.02.14i, In Vitro Chemosensitivity and Chemoresistance Assays
Independence Blue Cross·Oncology, Hematology·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
The policy for In Vitro Chemosensitivity and Chemoresistance Assays has been reissued with an effective date of October 1, 2025. This appears to be a routine policy reissuance rather than a content change, but the billing team should review the full policy details to identify any updates to coverage criteria or billing requirements.
Action Required
By October 1, 2025: Billing team should review the complete policy document at the source URL to identify any changes to coverage criteria, prior authorization requirements, or documentation standards for in vitro chemosensitivity and chemoresistance assays. Update billing procedures if any changes are identified.